Free Trial

Brainstorm Cell Therapeutics (BCLI) SEC Filings & 10K Form

Brainstorm Cell Therapeutics logo
$1.73 -0.07 (-3.89%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$1.73 0.00 (0.00%)
As of 02/21/2025 07:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Brainstorm Cell Therapeutics SEC Filings

DateFilerForm TypeView
02/14/2025
4:25 PM
ARMISTICE CAPITAL, LLC (Filed by)
Brainstorm Cell Therapeutics (Subject)
Form SCHEDULE 13G/A
01/21/2025
4:25 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2025
3:22 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:10 PM
Brainstorm Cell Therapeutics (Issuer)
Dagher Ibrahim B. (Reporting)
Form 3/A
01/07/2025
3:11 PM
Brainstorm Cell Therapeutics (Issuer)
Dagher Ibrahim B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:30 PM
ARBEL IRIT (Reporting)
Brainstorm Cell Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:31 PM
Bairu Menghisteab (Reporting)
Brainstorm Cell Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:31 PM
Brainstorm Cell Therapeutics (Issuer)
HARTOUNIAN HARTOUN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:32 PM
Brainstorm Cell Therapeutics (Issuer)
Lindborg Stacy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:32 PM
Brainstorm Cell Therapeutics (Issuer)
Naor Nir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:33 PM
Brainstorm Cell Therapeutics (Issuer)
Patlis Alla (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:34 PM
Brainstorm Cell Therapeutics (Issuer)
Yablonka Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:34 PM
Brainstorm Cell Therapeutics (Issuer)
Polverino Anthony J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:36 PM
Brainstorm Cell Therapeutics (Issuer)
FRENKEL JACOB A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:36 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
2:24 PM
ARMISTICE CAPITAL, LLC (Filed by)
Brainstorm Cell Therapeutics (Subject)
Form SC 13G
11/13/2024
6:55 AM
Brainstorm Cell Therapeutics (Subject)
Ruck Matthew J (Filed by)
Form SC 13G
10/30/2024
7:41 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
7:00 AM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
7:00 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2024
11:15 PM
Brainstorm Cell Therapeutics (Filer)
Form EFFECT
09/26/2024
3:30 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2024
3:30 PM
Brainstorm Cell Therapeutics (Filer)
Form S-3/A
09/17/2024
2:32 PM
Brainstorm Cell Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/16/2024
3:36 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2024
11:15 PM
Brainstorm Cell Therapeutics (Filer)
Form EFFECT
08/28/2024
4:01 PM
Brainstorm Cell Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/16/2024
6:00 AM
Brainstorm Cell Therapeutics (Filer)
Form DEF 14A
08/16/2024
6:03 AM
Brainstorm Cell Therapeutics (Filer)
Form ARS
08/14/2024
7:01 AM
Brainstorm Cell Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
6:15 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2024
3:08 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
07/31/2024
3:09 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
07/31/2024
3:05 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
07/31/2024
3:06 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
07/31/2024
3:06 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
07/31/2024
3:07 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
07/31/2024
3:07 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
07/24/2024
3:05 PM
Brainstorm Cell Therapeutics (Issuer)
Dagher Ibrahim B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:05 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
9:49 AM
Brainstorm Cell Therapeutics (Filer)
Form 424B5
Your trading day could end at 11 AM (Ad)

What do you usually do between 9:35 AM and 11:00 AM? Catch up on emails? Attend a meeting? Maybe grab a coffee? For me, it's become the most important part of my trading day. 85 minutes. That's usually all it takes. Set up at 9:35 AM… Check back at 11:00 AM. And when things work out, there's an extra $100 to $150 in my account… on a $1000 starting stake. Sounds too simple, doesn't it?

Tap this link and see the complete breakdown.
06/28/2024
6:30 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
8:00 AM
Brainstorm Cell Therapeutics (Filer)
Form 424B5
06/26/2024
3:01 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
8:03 PM
Brainstorm Cell Therapeutics (Issuer)
HARTOUNIAN HARTOUN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/25/2024
8:04 PM
Brainstorm Cell Therapeutics (Issuer)
HARTOUNIAN HARTOUN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:24 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
5:05 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
8:00 AM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:00 AM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
6:53 AM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
6:41 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
8:14 AM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
3:06 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
3:01 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:06 PM
Brainstorm Cell Therapeutics (Issuer)
Dagher Ibrahim B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/19/2024
5:05 AM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
8:31 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
5:10 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2024
5:05 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
3:15 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
8:16 AM
Brainstorm Cell Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/01/2024
7:15 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
7:54 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
7:55 PM
Brainstorm Cell Therapeutics (Issuer)
Patlis Alla (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
7:56 PM
Brainstorm Cell Therapeutics (Issuer)
Yablonka Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
7:57 PM
Brainstorm Cell Therapeutics (Issuer)
Lindborg Stacy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BCLI) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners